Clinical Trial Update: Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing paclitaxel-eluting and sirolimus-eluting stents against bare stents for de novo coronary lesions; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• Bare-metal stent (bare-metal stent)
• Cypher Sirolimus-Eluting Stent (sirolimus-eluting stent)
• TAXUS Paclitaxel-Eluting Stent (paclitaxel-eluting stent)

Snippet

Sponsor: Sahajanand Medical Technologies Limited | Conditions: Coronary Restenosis | Phase 4 | Status: COMPLETED